Pavia

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Amyloidosis2 trials
• Myasthenia gravis1 trial

Phase

• Phase 31 trial

Status

• Enrolling by invitation1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Alnylam Pharmaceuticals2 trials
• Alexion Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis

  NCT06967480· Alexion Pharmaceuticals, Inc.· Source

  Contact: Alexion Pharmaceuticals, Inc. (Sponsor)

• Enrolling by invitation

  A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT06679946· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

  NCT05040373· Alnylam Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis2 recruiting
• Myasthenia gravis1 recruiting